Brooks Laboratories Limited (NSE: BROOKS), ISIN INE650L01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BROOKS last traded at ₹60.90 (+1.35%), with a 52-week range of ₹36.90 to ₹165.95 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 52.62%, FIIs 0.17%, DIIs 10.38%, mutual funds 9.90%.
EquiSense Score (ECS): 49/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.